Quince Therapeutics Settles $16.4M Debt
Quince Therapeutics announced the settlement of the company's outstanding obligations under its loan from the European Investment Bank for a payment of $5.5M. Effective immediately upon the $5.5M payment, Quince settled outstanding EIB debt obligations of approximately $16.4M as of March 27. As a direct result of this $5.5M payment, all of the company's obligations under both the settlement agreement and the underlying loan agreement have been fully satisfied and discharged.
